<?xml version="1.0" encoding="UTF-8"?>
<p>At the start of the West Africa Ebola epidemic in 2014, and based upon prior outbreaks in which close to 90 percent of infected pregnant women and 100 percent of fetuses died as a result of EVD, it was generally believed that almost all, if not all, pregnant women with Ebola infection would soon succumb to the disease [
 <xref rid="B5-vaccines-08-00038" ref-type="bibr">5</xref>,
 <xref rid="B8-vaccines-08-00038" ref-type="bibr">8</xref>,
 <xref rid="B11-vaccines-08-00038" ref-type="bibr">11</xref>,
 <xref rid="B41-vaccines-08-00038" ref-type="bibr">41</xref>]. In an interview performed early in the West Africa epidemic, a representative from a non-governmental organization had opined that the survival rate for expectant mothers was virtually zero [
 <xref rid="B42-vaccines-08-00038" ref-type="bibr">42</xref>]. In a report published in 2015 [
 <xref rid="B43-vaccines-08-00038" ref-type="bibr">43</xref>], the probability for maternal and infant survival of EVD was summarized as follows:
</p>
